Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -17.84% is 20% above its 5-year average of -22.17%, near the high end of its 5-year range (-74.14%–5.13%).
As of the fiscal period ended Tuesday, June 30, 2026. 59.37% above its 12-month average of -43.91%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -17.84%.
RETURN ON EQUITY (ROE)
-17.84%
RETURN ON EQUITY (ROE) AVG TTM
-43.91%
RETURN ON EQUITY (ROE) AVG 3Y
-31.33%
RETURN ON EQUITY (ROE) AVG 5Y
-22.17%
RETURN ON EQUITY (ROE) AVG 10Y
-37.62%
RETURN ON EQUITY (ROE) AVG 15Y
-61.22%
RETURN ON EQUITY (ROE) AVG 20Y
-77.10%
CURRENT VS TTM AVG
+59.37%
CURRENT VS 3Y AVG
+43.07%
CURRENT VS 5Y AVG
+19.55%
CURRENT VS 10Y AVG
+52.59%
CURRENT VS 15Y AVG
+70.86%
CURRENT VS 20Y AVG
+76.86%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+57.54%
vs the sector median at left
Precision Optics Corporation, Inc.
Market Cap
$49.25M
Return on Equity (ROE)
-17.84%
TTM Avg
-43.91%
3Y Avg
-31.33%
5Y Avg
-22.17%
Market Cap
$48.99M
Return on Equity (ROE)
N/A
TTM Avg
-374.04%
3Y Avg
-326.22%
5Y Avg
-254.86%
Market Cap
$48.80M
Return on Equity (ROE)
N/A
TTM Avg
-382.07%
3Y Avg
-282.25%
5Y Avg
-171.00%
Market Cap
$49.58M
Return on Equity (ROE)
-90.44%
TTM Avg
-163.19%
3Y Avg
-112.62%
5Y Avg
-86.58%
Market Cap
$48.51M
Return on Equity (ROE)
-23.70%
TTM Avg
-170.56%
3Y Avg
-190.10%
5Y Avg
-146.13%
Market Cap
$50.72M
Return on Equity (ROE)
N/A
TTM Avg
-24.59%
3Y Avg
-14.57%
5Y Avg
93.61%
Market Cap
$49.96M
Return on Equity (ROE)
N/A
TTM Avg
296.81%
3Y Avg
-175.08%
5Y Avg
-1071.79%
Market Cap
$50.44M
Return on Equity (ROE)
-52.72%
TTM Avg
-32.48%
3Y Avg
-92.81%
5Y Avg
-85.98%
Market Cap
$50.00M
Return on Equity (ROE)
N/A
TTM Avg
31.64%
3Y Avg
119.26%
5Y Avg
-26.51%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision Optics Corporation, Inc. (POCI) | $49.25M | -17.84% | -43.91% | -31.33% | -22.17% |
| TELA Bio, Inc. (TELA)vs › | $48.99M | N/A | -374.04% | -326.22% | -254.86% |
| Apollomics, Inc. (APLM)vs › | $48.80M | N/A | -382.07% | -282.25% | -171.00% |
| INmune Bio, Inc. (INMB)vs › | $49.58M | -90.44% | -163.19% | -112.62% | -86.58% |
| Microbot Medical Inc. (MBOT)vs › | $48.51M | -23.70% | -170.56% | -190.10% | -146.13% |
| biote Corp. (BTMD)vs › | $50.72M | N/A | -24.59% | -14.57% | 93.61% |
| Clene Inc. (CLNN)vs › | $49.96M | N/A | 296.81% | -175.08% | -1071.79% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $50.44M | -52.72% | -32.48% | -92.81% | -85.98% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.00M | N/A | 31.64% | 119.26% | -26.51% |
| Sensus Healthcare, Inc. (SRTS)vs › | $47.90M | -42.01% | -2.07% | 11.82% | 5.22% |
ROE
-17.8%
ROA
-11.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -17.84% |
| 2026-03-31 | -24.51% |
| 2025-12-31 | -74.14% |
| 2025-09-30 | -55.90% |
| 2025-06-30 | -47.15% |
| 2025-03-31 | -43.93% |
| 2024-12-31 | -42.31% |
| 2024-09-30 | -37.47% |
| 2024-06-30 | -29.32% |
| 2024-03-31 | -14.53% |
| 2023-12-31 | -15.18% |
| 2023-09-30 | -3.85% |
| 2023-06-30 | -1.20% |
| 2023-03-31 | 2.28% |
| 2022-12-31 | 5.13% |
| 2022-09-30 | -5.69% |
| 2022-06-30 | -10.35% |
| 2022-03-31 | -19.23% |
| 2021-12-31 | -10.60% |
| 2021-09-30 | -16.87% |
| 2021-06-30 | -3.00% |
| 2021-03-31 | 0.48% |
| 2020-12-31 | -35.94% |
| 2020-09-30 | -47.10% |
| 2020-06-30 | -51.45% |
| 2020-03-31 | -43.62% |
| 2019-12-31 | -26.08% |
| 2019-09-30 | -11.66% |
| 2019-06-30 | -18.21% |
| 2019-03-31 | -20.10% |
| 2018-12-31 | -27.85% |
| 2018-09-30 | -102.33% |
| 2018-06-30 | -62.30% |
| 2018-03-31 | -124.76% |
| 2017-12-31 | -64.82% |
| 2017-09-30 | -92.42% |
| 2017-06-30 | -180.25% |
| 2017-03-31 | -122.59% |
| 2016-12-31 | -113.34% |
| 2016-09-30 | -266.81% |
| 2016-06-30 | -176.23% |
| 2016-03-31 | -181.11% |
| 2015-12-31 | -147.57% |
| 2015-09-30 | -328.10% |
| 2015-06-30 | -176.76% |
| 2015-03-31 | -123.87% |
| 2014-12-31 | -121.68% |
| 2014-09-30 | -89.48% |
| 2014-06-30 | -156.72% |
| 2014-03-31 | -104.22% |
| 2013-12-31 | -75.05% |
| 2013-09-30 | -106.99% |
| 2013-06-30 | -104.53% |
| 2013-03-31 | -99.26% |
| 2012-12-31 | -130.34% |
| 2012-09-30 | -58.15% |
| 2012-06-30 | 185.04% |
| 2012-03-31 | 128.91% |
| 2011-12-31 | 94.73% |
| 2011-09-30 | 135.29% |
| 2009-09-30 | -235.32% |
| 2009-06-30 | -205.70% |
| 2009-03-31 | -183.78% |
| 2008-12-31 | -127.29% |
| 2008-09-30 | -160.07% |
| 2008-06-30 | -115.78% |
| 2008-03-31 | -169.33% |
| 2007-12-31 | -213.25% |
| 2007-09-30 | -142.11% |
| 2007-06-30 | -124.71% |
| 2007-03-31 | -100.57% |
| 2006-12-31 | -197.11% |
| 2006-09-30 | -120.36% |
| 2006-06-30 | -86.08% |
| 2006-03-31 | -238.44% |
| 2005-12-31 | -189.33% |
| 2005-09-30 | -144.77% |
| 2005-06-30 | -129.43% |
| 2005-03-31 | -90.47% |
| 2004-12-31 | -79.09% |
| 2004-09-30 | -70.47% |
| 2004-06-30 | -244.96% |
| 2004-03-31 | -146.32% |
| 2003-12-31 | -87.19% |
| 2003-09-30 | -60.91% |
| 2003-06-30 | -56.43% |
